Home

Astrazeneca reported a 8.3% stake in Innate Pharma IPHA · 7,825,501 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
8.3%
Last report
No earlier report
Shares held
7,825,501 sh
Class
Ordinary Shares, EUR0.05 nominal value per share
Event date
25/12/22
Filed
26/02/06

8.3% stake

Innate Pharma trades, last 26 weeks

What else happened in Innate Pharma around then

Filed or reported within 30 days of the trade day · 25/11/22~01/21

Astrazeneca's other 5% stake reports

  • Astrazeneca

    5% stakeCellectis

    44% stake

    Filed 25/01/24